The 12 closest competitors and alternatives to Kyrok among industrial ai companies — ranked by similarity to what Kyrok actually does, not by market-cap band.
Subscribe to see Kyrok’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Kyrok is a company headquartered in Berlin, Germany, focused on modernizing pharma supply chains. It develops AI supply chain agents for the pharmaceutical and chemical industries, aiming to bring AI to these sectors.
Kyrok is an industrial ai company headquartered in Germany. Its most recent funding round, Pre-Seed, raised $3.4M in June 2026. Xcout tracks 2 named people at Kyrok, including Daniel Hofinger (Co-Founder & CEO).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Pre-Seed | $3.4M | 11 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to Kyrok by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
AI
Octozi provides a clinical intelligence platform that uses AI agents to automate clinical data workflows. The company helps the pharma industry accelerate drug approvals by streamlining processes such as data cleaning, review, reconciliation, reporting, and clinical operations.
AI/ML
Enjamb Labs provides an AI-powered agentic workspace designed for biopharma teams to manage drug development programs from discovery through FDA approval. Its platform integrates specialized AI agents to handle clinical evidence, trial design, statistical programming, and regulatory submissions within existing enterprise systems.
AI/ML
Hyro is a leading healthcare AI agent platform that automates call centers, patient scheduling, and access workflows for health systems.
AI/ML
Synagen AI is a bootstrapped healthcare technology company headquartered in Dresden, Germany, focused on developing pioneering AI-driven agents for oncology and medical advancements.
AI/ML
Phases deploys AI agents to oversee clinical trials, aiming to improve operational performance, data quality, and audit readiness by identifying risks. The company is headquartered in San Francisco, California, United States.
Artificial Intelligence & Biotechnology
Latent Labs Technologies operates as a frontier artificial intelligence laboratory that builds generative models for molecular biology. The company provides AI-driven tools and agents—such as Latent-Y, Latent-X2, and Latent-X—to help researchers and partners design drugs, create antibodies, optimize enzymes, and advance genetic engineering.
Artificial Intelligence
Hippocratic AI is a healthcare-focused artificial intelligence company developing safety-oriented generative AI agents for healthcare and other health-related workflows. Its systems are intended to support providers, payers, and other healthcare organizations with non-diagnostic tasks such as patient communication and administrative or operational assistance.
AI
Sci2sci is a Berlin-based startup that develops software, including a neurosymbolic memory layer and data catalog, designed to organize and manage data for the biotech and pharmaceutical industries.
AI/ML
Forgent AI GmbH is an artificial intelligence company headquartered in Berlin, Germany, that builds AI agents to serve infrastructure firms and high-tech suppliers participating in public tenders.
AI/ML
Owkin builds artificial intelligence solutions to automate biopharmaceutical research and development and support clinical research. Its core product, K Pro, is an AI agent that analyzes multimodal patient data to generate insights, inform decision-making, and assist biopharma and healthcare professionals.
AI/ML
Pillar Labs is a supply chain and technology software company that develops AI agentic research tools and planning software. The company focuses on enabling automated research using high-quality data.
AI/ML
B12 Labs provides an AI-powered software platform that automates and accelerates chemical synthesis for the pharmaceutical and biotechnology industries. Its tools assist researchers with retrosynthesis planning, reaction condition optimization, and the generation of execution-ready protocols for lab automation equipment.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Kyrokand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →